| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | Jun 28, 2023 | Acrivon Therapeutics, Inc. | 10% Owner | Sell | 52.5 | -16 | 0.00% | ✗ | $206.9 |
| Jun 15, 2023 | Jun 20, 2023 | Acrivon Therapeutics, Inc. | 10% Owner | Sell | 51.3 | -2,056 | -0.05% | ✗ | $25K |
| Jun 12, 2023 | Jun 14, 2023 | Acrivon Therapeutics, Inc. | 10% Owner | Sell | 47.5 | -5,893 | -0.15% | ✗ | $72.4K |
| Nov 17, 2022 | Nov 21, 2022 | Acrivon Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +400,000 | 11.57% | ✗ | $5M |